Concepedia

Author

I Forgács

King's College Hospital

Also Known As

I C Forgacs, I FORGACS, I Forgacs, I Forgács, I Forgãcs, I. C. Forgacs, I. Forgacs, I. Forgács, I.C. Forgacs, IAN C. FORGACS

154

Publications

3.5K

Citations

23

H-Index

72

Concepts

All Affiliations

King's College HospitalKing's College LondonSt Thomas' HospitalKing's College SchoolGuy's Hospital
IF

About

I Forgács is an author at King's College Hospital specializing in medicine, gastroenterology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

15

1K

2

Education

1

1

17

3

Humanities

1

1

17

4

Allergy

1

1

438

5

Cell Biology

1

1

29

I Forgács

×

25

Publications

2.4K

Citations

19

H-Index

YearCitations

Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease

Jeremy Tibble, G Sigthorsson, I Forgács,

Gastroenterology

2002

438

Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria.

Andrew J. Macpherson, U Y Khoo, I Forgács,

Gut

1996

437

Reduced bone density in patients with inflammatory bowel disease.

Ingvar Bjarnason, Andrew J. Macpherson, C. Mackintosh,

Gut

1997

368

Intrajejunal levodopa infusion in Parkinson's disease: A pilot multicenter study of effects on nonmotor symptoms and quality of life

Holger Honig, Angelo Antonini, Pablo Martínez‐Martín,

Movement Disorders

2009

271

Influence of gallstones and ursodeoxycholic acid therapy on gallbladder emptying

I Forgács, M. N. Maisey, G. M. Murphy,

Gastroenterology

1984

134

Scleromyxedema: Response to high-dose intravenous immunoglobulin (hdIVIg)

Robert K. Lister, Stephen Jolles, Sean Whittaker,

Journal of the American Academy of Dermatology

2000

91

Fecal M2-pyruvate kinase (M2-PK): A novel marker of intestinal inflammation

Guy Chung‐Faye, Bu Hayee, Susan Maestranzi,

Inflammatory Bowel Diseases

2007

89

Comparison of effects of ingested mediumand long-chain triglyceride on gallbladder volume and release of cholecystokinin and other gut peptides

P Isaacs, Spiros D. Ladas, I Forgács,

Digestive Diseases and Sciences

1987

56

Intrajejunal Levodopa Versus Conventional Therapy in Parkinson Disease

Prashanth Reddy, Pablo Martínez‐Martín, Alexandra Rizos,

Clinical Neuropharmacology

2012

56

Selective white cell apheresis reduces relapse rates in patients with IBD at significant risk of clinical relapse

Laurence Maiden, Ken Takeuchi, Rosie Baur,

Inflammatory Bowel Diseases

2008

52

Page 1